Get startedLog in
    Picture of Alkem Laboratories logo

    ALKEM — Alkem Laboratories Cashflow Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareConservativeLarge CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Alkem Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2021
    March 31st
    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    2025
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IAS
    IAS
    IAS
    IAS
    IAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line18,42118,44313,04820,23125,270
    Depreciation
    Non-Cash Items-1,099-954139843-2,534
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-7,418-9,419534-4,586-7,180
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Payable / Accrued Expenses
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities12,64911,11016,82519,48119,128
    Capital Expenditures-1,949-3,389-2,329-2,593-6,756
    Purchase of Fixed Assets
    Other Investing Cash Flow Items-8,036-10,9633,458-7,492-6,231
    Acquisition of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-9,985-14,3511,128-10,085-12,988
    Financing Cash Flow Items-536-401-905-913-806
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-2,7183,796-17,608-11,450-8,110
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-17.2580416-2,075-1,864